Biological age and immunosenescence in Colombian centenarians
Juan-Manuel Anaya1,2, Edward A Ruiz-Narváez3, Ivan David Lozada-Martinez4,5
1Colombian Centenarians Alliance, Bogotá, Colombia. anayajm@gmail.com.
Insights
Centenarians show varied biological aging, with better well-being linked to younger biological age. Distinct immune cell profiles and clinical factors correlate with advanced biological age, challenging typical immunosenescence notions in extreme longevity.
Area of Science:
- Geroscience
- Immunology
- Longevity Research
Background:
- Biological aging and immunosenescence are key to longevity.
- Their interaction in centenarians is not well understood.
- Centenarians represent a unique model for studying aging.
Purpose of the Study:
- To investigate the relationship between biological age (PhenoAge) and immunosenescence in Colombian centenarians.
- To identify clinical variables associated with biological age and immune status.
- To explore immune profiles in different centenarian aging trajectories.
Main Methods:
- Cross-sectional study of 160 Colombian centenarians.
- Assessed biological age using PhenoAge.
- Performed cytokine profiling and lymphocyte immunophenotyping.
- Collected data on quality of life, well-being, and clinical variables.
Main Results:
- Higher biological age associated with depressive symptoms, smoking history, elevated RANTES and G-CSF, and specific CD8+ T cell phenotypes (e.g., TEMRA cells).
- Better quality of life and well-being linked to lower biological age.
- Centenarians categorized as vigorous, resilient, or vulnerable showed similar cytokine levels.
Conclusions:
- Findings challenge the universal concept of immunosenescence in centenarians.
- Biological age is associated with specific clinical and immune factors in extreme longevity.
- Highlights the importance of translational geroscience research.
Abstract:
Biological aging and immunosenescence are central to longevity, yet their interplay in centenarians remains unclear. We conducted a cross-sectional study in 160 Colombian centenarians to examine associations between biological age (PhenoAge), immunosenescence and age-related clinical variables. Cytokine profiling (n = 114) and lymphocyte immunophenotyping (n = 42) were assessed. It was observed that better QoL and well-being were significantly associated with lower biological age, while depressive symptoms, prior tobacco use, elevated levels of RANTES and G-CSF as well as a distinct CD8+ T cell phenotype including greater CD27- CD28+ central memory, effector memory, and KLRG1- CD57+ terminally differentiated effector memory T cells (TEMRA), and fewer KLRG1+ CD57+ TEMRA cells were linked to higher biological age. Centenarians were classified into three categories: vigorous (10%), resilient (46.25%), and vulnerable (43.75%). Cytokine levels were similar across the groups. These findings challenge the notion of immunosenescence in centenarians and highlight the value of translational research in geroscience.
Related Concept Videos
The Effect of Aging on Tissues
Pharmacodynamics in Geriatric Patients: Effects of Age
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution


